Literature DB >> 32674907

Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice.

Yu-Jin Jung1, Ki-Hye Kim1, Eun-Ju Ko2, Youri Lee1, Min-Chul Kim3, Young-Tae Lee1, Cheol-Hyun Kim4, Subbiah Jeeva1, Bo Ryoung Park1, Sang-Moo Kang5.   

Abstract

Lactic acid bacteria Lactobacillus casei DK128 isolated from fermented vegetable foods was suggested to stimulate innate immune responses. Here, we investigated whether heat-killed DK128 would exhibit adjuvant effects on enhancing the efficacy of influenza vaccination. Immunization of mice with split influenza virus vaccine in the presence of heat-killed DK128 induced significantly higher levels of both IgG1 and IgG2c isotype antibodies than those by vaccine only. A single dose DK128-adjuvanted influenza vaccination conferred higher efficacy of protection, as evidenced by intact lung function, less weight loss, enhanced clearance of lung viral loads, and lower levels of inflammatory cytokines and infiltrates. Immunization of CD4 T cell-knockout (CD4KO) mice with influenza vaccine and DK128, but not with vaccine alone, induced isotype-switched IgG antibodies and protection against lethal challenge in CD4KO mice. The results in this study suggest heat-killed DK128 as a potential vaccine adjuvant, promoting the induction of IgG isotype switching in CD4-deficient condition and enhancing protective efficacy of split influenza vaccination in immunocompromised and immune-competent subjects.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjuvant; Influenza vaccine; Lactic acid bacteria

Mesh:

Substances:

Year:  2020        PMID: 32674907      PMCID: PMC7453881          DOI: 10.1016/j.vaccine.2020.06.075

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  52 in total

1.  Lactobacilli as natural enhancer of cellular immune response.

Authors:  Warren V Kalina; Mansour Mohamadzadeh
Journal:  Discov Med       Date:  2005-04       Impact factor: 2.970

Review 2.  TLR signaling.

Authors:  T Kawai; S Akira
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

Review 3.  The history of MF59(®) adjuvant: a phoenix that arose from the ashes.

Authors:  Derek T O'Hagan; Gary S Ott; Gary Van Nest; Rino Rappuoli; Giuseppe Del Giudice
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

4.  Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine.

Authors:  Eun-Ju Ko; Young-Tae Lee; Ki-Hye Kim; Youri Lee; Yu-Jin Jung; Min-Chul Kim; Yu-Na Lee; Taeuk Kang; Sang-Moo Kang
Journal:  J Immunol       Date:  2016-11-23       Impact factor: 5.422

5.  Lactobacillus plantarum displaying conserved M2e and HA2 fusion antigens induces protection against influenza virus challenge.

Authors:  Wen-Tao Yang; Gui-Lian Yang; Liang Zhao; Yu-Bei Jin; Yan-Long Jiang; Hai-Bin Huang; Chun-Wei Shi; Jian-Zhong Wang; Guan Wang; Yuan-Huan Kang; Chun-Feng Wang
Journal:  Appl Microbiol Biotechnol       Date:  2018-04-19       Impact factor: 4.813

6.  Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.

Authors:  Hye Suk Hwang; Ki-Hye Kim; Youri Lee; Young-Tae Lee; Eun-Ju Ko; SooJin Park; Jong Seok Lee; Byung-Cheol Lee; Young-Man Kwon; Martin L Moore; Sang-Moo Kang
Journal:  Hum Vaccin Immunother       Date:  2017-01-27       Impact factor: 3.452

7.  Genetic control of immune responses to influenza A matrix 2 protein (M2).

Authors:  Julia A Misplon; Chia-Yun Lo; Jon D Gabbard; S Mark Tompkins; Suzanne L Epstein
Journal:  Vaccine       Date:  2010-07-16       Impact factor: 3.641

8.  Mucosal vaccination with recombinant Lactobacillus casei-displayed CTA1-conjugated consensus matrix protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB/c mice.

Authors:  Mohammed Y E Chowdhury; Rui Li; Jae-Hoon Kim; Min-Eun Park; Tae-Hwan Kim; Prabuddha Pathinayake; Prasanna Weeratunga; Man Ki Song; Hwa-Young Son; Seung-Pyo Hong; Moon-Hee Sung; Jong-Soo Lee; Chul-Joong Kim
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

Review 9.  Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination.

Authors:  Agnieszka Wyszyńska; Patrycja Kobierecka; Jacek Bardowski; Elżbieta Katarzyna Jagusztyn-Krynicka
Journal:  Appl Microbiol Biotechnol       Date:  2015-03-10       Impact factor: 4.813

10.  Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10.

Authors:  Jie Sun; Rajat Madan; Christopher L Karp; Thomas J Braciale
Journal:  Nat Med       Date:  2009-02-22       Impact factor: 53.440

View more
  1 in total

1.  Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged mice.

Authors:  Noopur Bhatnagar; Ki-Hye Kim; Jeeva Subbiah; Bo Ryoung Park; Eun-Ju Ko; Baik-Lin Seong; Sang-Moo Kang
Journal:  Antiviral Res       Date:  2021-12-18       Impact factor: 5.970

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.